Press Release

Infectious Disease Testing is Witnessing High Growth in the Global Point-of-Care Diagnostics Market

August, 2019

" "

The global point-of-care diagnostics market is expected to witness a CAGR of 7.3% during the forecast period to touch $38.14 billion by 2025

Bangalore, India, August 2019: With its recently published study “Global Point-of-Care Diagnostics Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025”, Infoholic Research forecasts that the global point-of-care diagnostics market will continue to grow, owing to increasing prevalence of infectious diseases, growing patient base for life-style diseases, rising geriatric population, and heavy adoption of point-of-care diagnostics. Increasing awareness towards point-of-care diagnostics in developing countries and growth opportunities in the emerging markets are poised to support the market growth during the forecast period 2019–2025.

Access Full Report Summary @ https://www.infoholicresearch.com/report/point-of-care-diagnostics-market

The point-of-care diagnostics market, by products, is segmented into infectious disease testing, glucose monitoring, hematology testing, pregnancy and fertility testing, urinalysis testing, cardiometabolic monitoring, tumors or cancer marker testing, coagulation monitoring, cholesterol testing, drugs of abuse testing, and others. Among these, glucose monitoring occupied a dominant share in 2018, and infectious disease testing is expected to grow at a high CAGR during the forecast period 2019–2025. Increasing prevalence of diabetes, changing lifestyles, and growing demand for disease management made the glucose monitoring segment the largest shareholder in 2018. Infectious disease testing is further segmented into influenza testing, HIV testing, hepatitis testing, tuberculosis testing, sexually transmitted diseases testing, healthcare-associated infections testing, respiratory infections testing, and others. The prescription-based diagnostic tests occupied the largest share in 2018 with mid-single-digit CAGR, and over-the-counter-based point-of-care diagnostics is estimated to grow at the fastest rate during the forecast period 2019–2025. The introduction of portable point-of-care products, increasing demand for rapid tests among home care users, and growing preference for home or remote monitoring make home care the fastest-growing segment during the forecast period 2019–2025.

Get a sample copy of the report @ https://www.infoholicresearch.com/request-a-sample-report/?repid=14489

The global point-of-care diagnostics market is segmented across regions such as North America, Europe, Asia Pacific, and Rest of the World. North America occupied a significant market share in 2018, and Asia Pacific is likely to grow at a high CAGR during the forecast period. Favorable reimbursement facilities, presence of dominant players in the region, availability of hi-tech medical technologies, and increasing patient base for lifestyle diseases make North America a dominant shareholder in the market.

The point-of-care diagnostics technology has revolutionized disease screening and diagnosis. This has become an efficient alternative for frequent and rapid diagnosis at the patient’s location. The market is growing at a steady pace with an increase in investments for the launch and approval of innovative products. For instance, in January 2018, Abbott announced the launch of CE-marked Alinity h-series integrated system for hematology testing. Growing awareness and upsurge in disease incidence will further increase the need for advanced products in the market.” pointed out Arpitha Shetty, Research Analyst, Infoholic Research

Key Segments of the Report Include:

  • By Products:
    • Infectious Disease Testing (Influenza Testing, HIV Testing, Hepatitis Testing, Tuberculosis Testing, Sexually Transmitted Diseases Testing, Healthcare-associated Infections Testing, Respiratory Infections Testing, Others)
    • Glucose Monitoring
    • Hematology Testing
    • Pregnancy and Fertility Testing
    • Urinalysis Testing
    • Cardiometabolic Monitoring
    • Tumors or Cancer Marker Testing
    • Coagulation Monitoring
    • Cholesterol Testing
    • Drugs of Abuse Testing
    • Others
  • By Prescription Mode:
    • Prescription-based Point-of-Care Diagnostics
    • Over-the-Counter-based Point-of-Care Diagnostics
  • By End-users:
    • Hospitals
    • Clinics/Physician Office Laboratory
    • Home Care
    • Ambulatory Care
    • Others
  • By Regions:
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World
  • Industry Outlook: Market trends, drivers, restraints, and opportunities

Contact: Ms. Sunanda Ganguli

Infoholic Research LLP

IND: 080-461-51400

USA: 1-661-210-1186

sunanda@infoholicresearch.com